Figure 2.

Uncovering new opportunities and perspectives in APS research. Despite the advancements in new technologies, the field of APS still faces a shortage of large-scale studies. However, with the emergence of multi-omics technologies and innovative computational tools, particularly machine learning methodologies, there is an unprecedented opportunity to transform APS research. Integrating diverse clinical and molecular data from extensive cohorts of patients using these cutting-edge approaches holds the potential to unlock novel pathological mechanisms underlying APS. Additionally, these methods offer the promise of identifying previously unknown biomarkers and therapeutic targets. As a result, the development of precision medicine in APS can be significantly accelerated, offering more tailored and effective treatments to patients